United States · Biotechnology startup
United States · Generate Biomedicines
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
Funding reportedLast round: Series C
What company datasets say Generate Biomedicines raised
Funding, as reported
Reported in all$693Min dollars
Rounds3
Last roundSeries C
Last round dateSept 2023
Investors listed15
Valuation$1.0B, Oct 2024
Founders and team
From Generate Biomedicines's own website: 1 founder, 16 on the team.
Gevorg GrigoryanCo-Founder & Chief Technology Officer
- Jason SilversPresident & Chief Financial Officer
- Michael NallyChief Executive Officer
- Daria HazudaSenior Vice President, Discovery Strategy
- Dinesh de AlwisSenior Vice President, Head of Clinical Drug Development
- Sahm NasseriSenior Vice President, Business Development and Strategy
- Aarif KhakooChief Scientific Officer
- Beth GrousChief People Officer
- Sean MartinChief Legal Officer & General Counsel
- Frances ArnoldDirector
- Jane MendilloDirector
- Marsha FanucciDirector
- Nancy SimonianDirector
- Noubar AfeyanChair of the Board
- Paul ParkerDirector
- Rupert VesseyDirector
- Stéphane BancelDirector
On 3 portfolio pages
Investors who name them
Each firm lists Generate Biomedicines on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Generate Biomedicines in front of investors. Or tell us what we have wrong.